Bradesco Subsidiary Atlântica Invests in Hospitals
Ticker: BBDO · Form: 6-K · Filed: May 9, 2024 · CIK: 1160330
| Field | Detail |
|---|---|
| Company | Bank Bradesco (BBDO) |
| Form Type | 6-K |
| Filed Date | May 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: subsidiary, investment, healthcare
Related Tickers: BBD
TL;DR
Bradesco's hospital arm, Atlântica, is making moves in the healthcare investment space.
AI Summary
Banco Bradesco S.A. announced on May 8, 2024, that its indirect subsidiary, Atlântica Hospitais e Participações S.A., is involved in an investment in hospitals. Atlântica is controlled by Bradseg Participações S.A., which is also an indirect subsidiary of Bradesco.
Why It Matters
This filing indicates Bradesco's continued strategic investment in the healthcare sector through its subsidiaries, potentially impacting its financial performance and market position.
Risk Assessment
Risk Level: low — The filing is an informational update regarding subsidiary activities and does not present immediate financial risks.
Key Players & Entities
- Banco Bradesco S.A. (company) — Registrant
- Atlântica Hospitais e Participações S.A. (company) — Indirect subsidiary of Bradesco
- Bradseg Participações S.A. (company) — Controlling company of Atlântica
- May 8, 2024 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information regarding the activities of Banco Bradesco S.A., specifically concerning its indirect subsidiary Atlântica Hospitais e Participações S.A.
Who is Atlântica Hospitais e Participações S.A. and what is its relationship to Bradesco?
Atlântica Hospitais e Participações S.A. is a company focused on hospital investments and is an indirect subsidiary of Banco Bradesco S.A.
Which entity controls Atlântica Hospitais e Participações S.A.?
Atlântica Hospitais e Participações S.A. is controlled by Bradseg Participações S.A., which is also an indirect subsidiary of Bradesco.
What is the filing period for this report?
The conformed period of report is for the month of May, 2024, with the filing date as of May 9, 2024.
Does Bradesco file its annual reports under Form 20-F or 40-F?
Bradesco indicates it files its annual reports under cover of Form 20-F.
Filing Stats: 651 words · 3 min read · ~2 pages · Grade level 14.4 · Accepted 2024-05-08 18:21:58
Filing Documents
- bbd20240508_6k.htm (6-K) — 11KB
- bbd202405086k_001.jpg (GRAPHIC) — 27KB
- 0001292814-24-001938.txt ( ) — 49KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 8, 2024 BANCO BRADESCO S.A. By: /S/ André Costa Carvalho André Costa Carvalho Investor Relations Officer
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.